Blade Q2 revenue up 175% to $35.6M; net income $8.4M vs loss year ago

Strata Critical Medical, Inc.

2022-Q2 EPS reported -$0.04 revenue$62,263,000

Total revenue $35.6M, up 175% YoY; MediMobility revenue $17.2M (+1,013%) driven by Trinity acquisition.
Short Distance revenue $11.0M (+89%) on Helijet acquisition and higher pricing; Flight Margin 14.3% vs 23.0% YoY.
Net income $8.4M vs net loss $24.3M year ago; adjusted EBITDA loss $(6.1)M vs $(2.6)M.
Europe acquisitions of three urban air mobility operators expected to close late Summer 2022.
JetBlue partnership launched June 23; Blade Airport service run-rate above pre-pandemic levels.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.